Skip to main
MASS
MASS logo

908 Devices (MASS) Stock Forecast & Price Target

908 Devices (MASS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

908 Devices Inc. is positioned favorably due to heightened growth prospects in its Handheld segment, bolstered by the recent acquisition of RedWave, which is anticipated to contribute $11 million to FY24 revenue with a growth rate exceeding 20%. Improvements in product technology and operational efficiencies are expected to drive demand and lead to a resurgence in Desktop revenues, ultimately enhancing overall cash flow. The CEO's recent stock purchases indicate strong confidence in the company’s forward momentum, reinforcing the belief in 908 Devices' positive trajectory within its market sectors.

Bears say

908 Devices Inc faces several challenges that contribute to a negative financial outlook. Firstly, a potential slowdown in cell and gene therapy spending could negatively impact growth expectations, particularly if funding within the biotech sector declines or if bioprocessing growth does not meet investor expectations. Additionally, delays in reimbursement for Exosome tests and tightened research budgets in academic institutions pose further risks to revenue growth, which are compounded by currency fluctuations from international operations.

908 Devices (MASS) has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of 908 Devices and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About 908 Devices (MASS) Forecast

Analysts have given 908 Devices (MASS) a Buy based on their latest research and market trends.

According to 4 analysts, 908 Devices (MASS) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

908 Devices (MASS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.